Last reviewed · How we verify

NCT06060626

Optimization of Sedation Protocol for Endoscopic Procedures Using Impedance Ventilation Monitor.

Completed NA Last updated 28 January 2025
What this trial tests

NA trial testing Sedation using only Propofol. in Sedation Complication in 50 participants. Completed in 22 January 2025.

Timeline
16 November 2023
Primary endpoint
22 January 2025
22 January 2025

Quick facts

Lead sponsorCharles University, Czech Republic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment50
Start date16 November 2023
Primary completion22 January 2025
Estimated completion22 January 2025
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

Charles University, Czech Republic

Who can join

Adults 18 to 65, any sex, with Sedation Complication or Ventilatory Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate the effect of opioids administered during sedation on patients' respiratory activity (ventilation) and comfort of the operator and patient during the endoscopic procedure. A common side effect of sedation is the effect on patients' ventilation, resulting from a combination of attenuation of respiratory centre activity and loss of patent airways. Shallow sedation will reduce these risks, but in addition to patient discomfort, it also increases the difficulty or impossibility of the endoscopist to perform the procedure. Choosing the appropriate method of sedation thus fundamentally affects the course of the procedure from the point of view of both the patient and the endoscopist. The aim is to prove that sedation with propofol alone compared to sedation with propofol and fentanyl premedication leads to the need for higher cumulative doses of administered propofol, higher risk of respiratory depression and lower patient and operator comfort. In addition, the non-invasive respiratory volume monitor (ExSpiron 2Xi) will be used for standard patient monitoring during the procedure, which assesses the lung tidal volume and respiratory rate by measuring the electrical impedance of the chest. This measurement captures inadequate ventilation before saturation drops, allowing even slight differences between selected drugs to be compared.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of opioid addition on procedural conditions during colonoscopy: a randomized trial comparing propofol-based sedation protocols.
    Novotny D, Palenik J, Tyll T, Brodyuk N, et al · · 2025 · cited 1× · PMID 40611561 · DOI 10.5946/ce.2024.347

Verify or expand the search:

Other recruiting trials for Sedation Complication

Currently open trials in the same condition.

Other Charles University, Czech Republic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06060626.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing